Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Flexion Therapeutics (Nasdaq:FLXN) announced that CEO Michael Clayman will participate in a virtual fireside chat at the H.C.

Rhea-AI Summary

Flexion Therapeutics (Nasdaq:FLXN) announced that CEO Michael Clayman will participate in a virtual fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021. The presentation will be available as an on-demand webcast starting at 7 a.m. ET on September 13 and can be accessed through the Flexion website. Flexion focuses on developing local therapies for musculoskeletal conditions, including osteoarthritis. For more details, visit Flexion's Investor Relations page.

Argus Session date unavailable

-0.62% session move Open Argus

Details

News Market Reaction – FLXN

The recorded move for FLXN in the trading session of this news was -0.62%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in a virtual analyst-led fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference taking place September 13-15, 2021.

The presentation will be available through an on-demand webcast beginning at 7 a.m. ET on September 13, 2021, and will be accessible on the Flexion website at http://ir.flexiontherapeutics.com.

About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Please visit flexiontherapeutics.com.

Contact:

Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Flexion Therapeutics participate in the H.C. Wainwright Global Investment Conference?

Flexion Therapeutics will participate in the H.C. Wainwright Global Investment Conference from September 13-15, 2021.

What time will the Flexion Therapeutics presentation be available?

The Flexion Therapeutics presentation will be available as an on-demand webcast beginning at 7 a.m. ET on September 13, 2021.

Where can I watch the Flexion Therapeutics presentation?

You can watch the Flexion Therapeutics presentation on their website at http://ir.flexiontherapeutics.com.

What is Flexion Therapeutics focused on developing?

Flexion Therapeutics is focused on developing local therapies for the treatment of musculoskeletal conditions, particularly osteoarthritis.